Transvaginal Ultrasound for Heavy Menstrual Bleeding
Any woman with heavy menstrual bleeding (HMB) that interferes with her physical, emotional, or social quality of life should undergo transvaginal ultrasound evaluation, regardless of the specific volume of blood loss. The decision is based on clinical impact rather than a specific quantitative threshold 1.
Clinical Definition and Threshold
Heavy menstrual bleeding is defined as excessive menstrual blood loss (>80 mL per cycle) that interferes with quality of life 2. However, the practical trigger for imaging is not a measured volume but rather clinical indicators that suggest significant bleeding:
Key Clinical Indicators for Imaging:
- Clots ≥1 inch in diameter
- "Flooding" (changing pad/tampon more frequently than hourly)
- Low ferritin levels or anemia
- Any bleeding pattern that impairs quality of life 3
These predictive features are more clinically useful than attempting to measure actual blood loss, which is impractical in routine practice.
When to Order Transvaginal Ultrasound
Transvaginal ultrasound is the first-line imaging test for all women with HMB 1, 4. The ACR Appropriateness Criteria (2020) designate transvaginal ultrasound as "usually appropriate" for abnormal uterine bleeding evaluation 1.
Specific Indications:
- Any HMB affecting quality of life (primary indication)
- Anemia from blood loss (check hemoglobin and ferritin)
- Flooding or large clots as described above
- Age ≥45 years with any AUB (higher risk of structural pathology) 5
- Personal or family history of bleeding disorders (warrants both imaging and hematologic evaluation) 3, 6
Important Caveats
Timing Considerations:
Recent evidence suggests days 11-13 of the menstrual cycle (follicular phase) is optimal for detecting endometrial polyps, with 82.5% sensitivity and 73% specificity 7. This timing consideration can reduce diagnostic errors.
Limitations of Transvaginal Ultrasound:
Transvaginal ultrasound cannot completely visualize the uterus in all women 1. Factors limiting visualization include:
- Uterine position (unfavorable angles of insonation)
- Adenomyosis
- Leiomyomas
- Patient body habitus
When transvaginal ultrasound is suboptimal, a multimodal approach should be used, including transabdominal ultrasound, transrectal ultrasound, or saline contrast sonohysterography 8. This multimodal approach avoided unnecessary invasive procedures in 30.5% of cases in a 2026 study 8.
Additional Imaging:
- 3D ultrasound with coronal reconstruction can improve spatial assessment 1, 4
- Saline infusion sonohysterography enhances diagnostic accuracy for intracavitary lesions 9, 5
- MRI with diffusion-weighted imaging should be considered when ultrasound cannot adequately visualize the endometrium, particularly in the presence of fibroids or adenomyosis 1
Critical Risk Stratification
Women with cavity-distorting fibroids have 10 times the odds of suboptimal transvaginal ultrasound and may require the multimodal approach or MRI from the outset 8.
Younger women and those with fibroids are at significantly higher risk of inadequate endometrial assessment with transvaginal ultrasound alone 8.
Bottom Line Algorithm
- Any HMB with quality of life impact → Order transvaginal ultrasound
- Check hemoglobin and ferritin to assess anemia severity
- If flooding, large clots, or low ferritin → Proceed with imaging regardless of patient's subjective assessment
- Schedule ultrasound on days 11-13 of cycle when possible for optimal polyp detection
- If transvaginal ultrasound is suboptimal → Use multimodal sonographic approach before proceeding to invasive procedures
- If fibroids or adenomyosis limit visualization → Consider MRI with diffusion-weighted imaging
There is no specific "heaviness threshold" below which imaging can be safely deferred—the presence of HMB affecting quality of life is itself the indication for transvaginal ultrasound evaluation 1, 9.